The two are related but not identical, and most of the strongest primary data concern thymosin 4 itself
Phase 2 trial (Lancet 2021) tested cagrilintide 0.3 mg through 4.5 mg/week as monotherapy and reported a clear dose-response, with 10.8% mean weight loss at 4.5 mg/week at 26 weeks
Ideal for clinical settings, medical facilities, and professional use
Injections are self-administered subcutaneously, typically in the abdomen or thigh, once per week
How much does PlexusDx oral semaglutide cost, and does price change with dose increases
The average weight loss results were as follows: Meanwhile, another study tested individuals with a Body Mass Index (BMI) of at least 30 and found that: Another key result from the STEP UP trials was that approximately 84.5% of weight loss came from body fat rather than lean body mass (LBM)